US3664964A - Eluent for radioisotopes - Google Patents

Eluent for radioisotopes Download PDF

Info

Publication number
US3664964A
US3664964A US742128A US3664964DA US3664964A US 3664964 A US3664964 A US 3664964A US 742128 A US742128 A US 742128A US 3664964D A US3664964D A US 3664964DA US 3664964 A US3664964 A US 3664964A
Authority
US
United States
Prior art keywords
eluent
percent
oxidizing agent
solution
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US742128A
Inventor
Thomas A Haney
Gerald A Bruno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of US3664964A publication Critical patent/US3664964A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005Isotope delivery systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01GWEIGHING
    • G01G23/00Auxiliary devices for weighing apparatus
    • G01G23/18Indicating devices, e.g. for remote indication; Recording devices; Scales, e.g. graduated
    • G01G23/20Indicating weight by mechanical means
    • G01G23/30Indicating weight by mechanical means with means for illuminating the scale
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M6/00Primary cells; Manufacture thereof
    • H01M6/42Grouping of primary cells into batteries
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B1/00Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
    • H04B1/06Receivers
    • H04B1/08Constructional details, e.g. cabinet
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • G21G2001/0042Technetium

Definitions

  • radioactive isotopes such as lodine Technetium 99", Yttrium, and many others, such as l-131, ST-85, Sr--87" and P-32, have been used in the medical and biological fields as tracer elements for investigative and diagnostic purposes and in some cases as a therapeutic agent.
  • Many of these radioactive isotopes are delivered to the user by means of a generator, wherein the radioactive isotope is contained on an ion exchange resin in its parent form.
  • the generator thus utilized has become known to the art as a cow and the operation of eluting the daughter isotope from its parent has become known as a milking" process.
  • the eluent in this invention is a saline solution which is prepared by methods known to the art.
  • the saline solution may be 0.9 percent sodium chloride solution or an isotonic sodium chloride solution.
  • the oxidizing agent added to this solution may be oxygen (bubbling it through the solution), an alkali metal hypochlorite (e.g., sodium hypochlorite), an alkali metal permanganate (e.g., potassium permanganate), ferthe radioisotope to be separated or eluted from the generator.
  • the method of utilizing the modified eluent of this invention is the same as customarily utilized in eluting generators whether they be of the sterile of non-sterile type.
  • Solution E 0.9% Sodium chloride with 0.01% available chlorine H 5.5.
  • Solutions C, and E which are isotonic chlorine saline solu- TABLE 1 [Tc yield using various eluting solutions]
  • Generator MC Milking 'Ic T0 o Potency eluent MC /25 percent MO Gen. Milking assayed label solution ml. of label content 128 100 B 105 105 N one. 2 100 78 B 72 92 Do. 100 1110..-- 78 61 B 52 85 Do. 4 61 47 D0. 47 37 E 34. 2 92 D0. is 316 200 B 130 65 Do. 2 246 156 B 70 Do. 200 mc 192 122 B 47 39 Do. 4 150 95 Do.
  • ric chloride hydrogen peroxide and an alkali metal perhalogenate (e.g., potassium perchloride, sodium perbromide, and so forth).
  • alkali metal perhalogenate e.g., potassium perchloride, sodium perbromide, and so forth.
  • organic and inorganic oxidizing agents such as peracetic acids, cupric acetate, iodoisobenzene, phenanthrenequinone, and pyridine N-oxide may also be utilized in the practice of this invention.
  • the concentration of the oxidizing agent on a v/v basis should be in the range of from about 0.01 percent to 0.1 percent. However, depending upon the oxidizing agent utilized, a concentration in the range of from about 0.001 percent to about 1 percent may be preferable. However, it has been discovered that extremely satisfactory results are obtained when the concentration of the oxidizing agent is in the range on a v/v basis of from about 0.02 percent to about 0.05 percent.
  • the initial eluent may be sterilized water, sterilized saline solution, an acid eluent or basic eluent depending upon the ion exchange resin utilized in the cow and From the above Table it is established that the yield of Technetium 99" can be significantly increased by utilizing isotonic chlorine water.
  • An eluent solution for use in eluting radioactive isotopes from an ion exchange resin consisting essentially of an isotonic saline solution and an oxidizing agent said oxidizing agent being present in a concentration of from about 0.001 percent to about 1.0 percent on a volume/volume ratio.
  • oxidizing agent is selected from the group consisting of oxygen, an alkali metal hypochlorite, an alkali metal permanganate, an alkali metal perhalogenate, ferric chloride, hydrogen peroxide, peracetic acids, cupric acetate, iodoisobenzene, phenanthrene-quinone and pyridine N-oxide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Electrochemistry (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Manufacturing & Machinery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

This disclosure relates to an eluent which improves the yield of nuclear radioisotopes from ion exchange resins. The disclosure in essence concerns itself with the addition of an oxidizing agent to an isotonic saline solution, said oxidizing agent being present in a concentration of from about 0.001 percent to about 1.0 percent on a volume/volume ratio.

Description

United States Patent Haney et a1.
451 May23, 1972 ELUENT FOR RADIOISOTOPES lnventors: Thomas A. Haney, East Brunswick; Gerald A. Bruno, Shrewsbury, both of NJ.
Assignee: E. R. Squibb & Sons, Inc., New York,
Filed: July 3, 1968 Appl. No.: 742,128
U.S. Cl ..252/364, 23/338, 210/31, 252/301.1 R
Int. Cl. ..B0lf l/00, C22b 61/04 Field of Search ..252/364, 95; 23/50 BE, 338; 210/31 C References Cited UNlTED STATES PATENTS 2,780,514 2/1957 Lutz ..23/338 3,002,823 10/1961 Flodin et al.. ...2l0/3l X 3,393,153 7/1968 Zimmerer et al. ..252/95 Primary ExaminerRichard D. Lovering Attorney-Lawrence S. Levinson and Merle J. Smith [57] ABSTRACT 4 Claims, No Drawings ELUENT FOR RADIOISOTOPES In recent years radioactive isotopes such as lodine Technetium 99", Yttrium, and many others, such as l-131, ST-85, Sr--87" and P-32, have been used in the medical and biological fields as tracer elements for investigative and diagnostic purposes and in some cases as a therapeutic agent. Many of these radioactive isotopes are delivered to the user by means of a generator, wherein the radioactive isotope is contained on an ion exchange resin in its parent form. By utilizing the proper eluent one is able to separate the daughter isotope from the parent which is adsorbed on an ion exchange resin. The generator thus utilized has become known to the art as a cow and the operation of eluting the daughter isotope from its parent has become known as a milking" process.
Recently, new sterile generators which are sterile and nonpyrogenic have been developed and are presently on the market. The milking of these generators is different in that hypodermic needles and syringes must be utilized and a sterile condition maintained throughout the operation. However, the present invention relates to both non-sterile and sterile generators.
It has been discovered that by the addition of an oxidizing agent to an eluent solution, the yield of the daughter isotope is significantly increased.
The eluent in this invention is a saline solution which is prepared by methods known to the art. The saline solution may be 0.9 percent sodium chloride solution or an isotonic sodium chloride solution. The oxidizing agent added to this solution may be oxygen (bubbling it through the solution), an alkali metal hypochlorite (e.g., sodium hypochlorite), an alkali metal permanganate (e.g., potassium permanganate), ferthe radioisotope to be separated or eluted from the generator. The method of utilizing the modified eluent of this invention is the same as customarily utilized in eluting generators whether they be of the sterile of non-sterile type.
The following examples illustrate the utilization of the eluent in the separation of various radioisotopes. In these examples all degrees are in Centigrade, unless otherwise stated:
EXAMPLES 1 TO 20 The following solutions are prepared by procedures known to the art, except as otherwise stated:
Solution A Normal isotonic saline with parabens.
Solution B 0.9% Sodium chloride solution.
Solution C 0.9% Sodium chloride solution with 0.5%
available chlorine pH 5.3.
Solution D 0.9% Sodium chloride solution with 0.5%
available chlorine pH 4.5.
Solution E 0.9% Sodium chloride with 0.01% available chlorine H 5.5. Solutions C, and E which are isotonic chlorine saline solu- TABLE 1 [Tc yield using various eluting solutions] Generator MC Milking 'Ic T0 o Potency eluent MC /25 percent MO Gen. Milking assayed label solution ml. of label content 128 100 B 105 105 N one. 2 100 78 B 72 92 Do. 100 1110..-- 78 61 B 52 85 Do. 4 61 47 D0. 47 37 E 34. 2 92 D0. is 316 200 B 130 65 Do. 2 246 156 B 70 Do. 200 mc 192 122 B 47 39 Do. 4 150 95 Do. 117 74 E )5 128 Do. 560 421 A 365 87 Do. 2d 266 200 A 11 5. 5 D0. 200 me, 2d (i'e milk) 266 200 C 165 83 Do. 3d 207 156 A 170 10!] Do. 162 122 A 110 00 D0. 790 632 A 416 66 Do. 375 300 A 13 4. 3 D0. 300 m(. 293 234 A 23 10 D0. 4 h 288 183 A 21 11.5 D0. 4th (re milk) 288 183 D 110 60 Do.
ric chloride, hydrogen peroxide and an alkali metal perhalogenate (e.g., potassium perchloride, sodium perbromide, and so forth). It is to be understood that both organic and inorganic oxidizing agents, such as peracetic acids, cupric acetate, iodoisobenzene, phenanthrenequinone, and pyridine N-oxide may also be utilized in the practice of this invention.
It has been found that a pH of the eluent of from about 3.0 to about 7.0 is effective. However, superior results were obtained when the eluent was maintained at a pH of from about 4 to about 6.8 with the best results being observed when the pH of the eluate was from about 5 to about 6.5.
The concentration of the oxidizing agent on a v/v basis should be in the range of from about 0.01 percent to 0.1 percent. However, depending upon the oxidizing agent utilized, a concentration in the range of from about 0.001 percent to about 1 percent may be preferable. However, it has been discovered that extremely satisfactory results are obtained when the concentration of the oxidizing agent is in the range on a v/v basis of from about 0.02 percent to about 0.05 percent.
As indicated above the initial eluent may be sterilized water, sterilized saline solution, an acid eluent or basic eluent depending upon the ion exchange resin utilized in the cow and From the above Table it is established that the yield of Technetium 99" can be significantly increased by utilizing isotonic chlorine water.
The invention may be variously otherwise embodied within the scope of the appended claims.
What is claimed is:
1. An eluent solution for use in eluting radioactive isotopes from an ion exchange resin consisting essentially of an isotonic saline solution and an oxidizing agent said oxidizing agent being present in a concentration of from about 0.001 percent to about 1.0 percent on a volume/volume ratio.
2. An eluent in accordance with claim 1 wherein the oxidizing agent is selected from the group consisting of oxygen, an alkali metal hypochlorite, an alkali metal permanganate, an alkali metal perhalogenate, ferric chloride, hydrogen peroxide, peracetic acids, cupric acetate, iodoisobenzene, phenanthrene-quinone and pyridine N-oxide.
3. An eluent in accordance with claim 1 wherein the pH of the eluent is from about 3.0 to about 7.0.
4. An eluent in accordance with claim 1 wherein the oxidizing agent is present in a concentration of from about 0.01 percent to 0. 1 percent on a volume/volume ratio.

Claims (3)

  1. 2. An eluent in accordance with claim 1 wherein the oxidizing agent is selected from the group consisting of oxygen, an alkali metal hypochlorite, an alkali metal permanganate, an alkali metal perhalogenate, ferric chloride, hydrogen peroxide, peracetic acids, cupric acetate, iodoisobenzene, phenanthrene-quinone and pyridine N-oxide.
  2. 3. An eluent in accordance with claim 1 wherein the pH of the eluent is from about 3.0 to about 7.0.
  3. 4. An eluent in accordance with claim 1 wherein the oxidizing agent is present in a concentration of from about 0.01 percent to 0.1 percent on a volume/volume ratio.
US742128A 1968-07-03 1968-07-03 Eluent for radioisotopes Expired - Lifetime US3664964A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74212868A 1968-07-03 1968-07-03

Publications (1)

Publication Number Publication Date
US3664964A true US3664964A (en) 1972-05-23

Family

ID=24983595

Family Applications (1)

Application Number Title Priority Date Filing Date
US742128A Expired - Lifetime US3664964A (en) 1968-07-03 1968-07-03 Eluent for radioisotopes

Country Status (10)

Country Link
US (1) US3664964A (en)
BE (1) BE735608A (en)
CA (1) CA929685A (en)
CH (1) CH501425A (en)
CS (1) CS161858B2 (en)
DE (1) DE1929067A1 (en)
ES (1) ES369006A1 (en)
FR (1) FR2012258A1 (en)
GB (1) GB1280537A (en)
NL (1) NL6910212A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991154A (en) * 1972-10-20 1976-11-09 Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung Method of reprocessing fuel and/or breeder material containing thorium dissolved in an acid solution
US4406877A (en) * 1980-06-04 1983-09-27 E. R. Squibb & Sons, Inc. 82 Rb Generating method and eluent
US4837110A (en) * 1985-09-03 1989-06-06 Hoechst Aktiengesellschaft Technetium-99m generator, its preparation and its use
DE102006058542A1 (en) * 2006-12-12 2008-06-19 Isotopen Technologien München AG Column system for producing a solution with high specific activity
US20130336437A1 (en) * 2012-06-15 2013-12-19 Dent International Research, Inc. Apparatus and methods for transmutation of elements
US20150139870A1 (en) * 2011-03-17 2015-05-21 Perma-Fix Environmental Services, Inc. Preparation of chitosan-based microporous composite material and its applications

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL165321C (en) * 1971-03-02 1981-03-16 Byk Mallinckrodt Cil Bv METHOD FOR THE MANUFACTURE OF A RADIO ISOTOPE GENERATOR GENERATOR.
DE2740822C2 (en) * 1977-09-10 1985-01-03 Grundig E.M.V. Elektro-Mechanische Versuchsanstalt Max Grundig & Co KG, 8510 Fürth TV receiver with slide-in compartment
DE2906439A1 (en) * 1979-02-20 1980-09-04 Hoechst Ag METHOD FOR SEPARATING TECHNETIUM-99M FROM MOLYBAEN-99
DE3103534C2 (en) * 1981-02-03 1983-09-08 Varta Batterie Ag, 3000 Hannover Battery case made of plastic
DE4110128A1 (en) * 1990-04-09 1991-11-07 Westinghouse Electric Corp DECONTAMINATION OF RADIOACTIVELY ATTRACTED METALS
CN111485123B (en) * 2020-04-13 2022-04-19 中国科学院近代物理研究所 Separation from large-amount and low-specific-activity Mo solution99mTc device and method

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991154A (en) * 1972-10-20 1976-11-09 Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung Method of reprocessing fuel and/or breeder material containing thorium dissolved in an acid solution
US4406877A (en) * 1980-06-04 1983-09-27 E. R. Squibb & Sons, Inc. 82 Rb Generating method and eluent
US4837110A (en) * 1985-09-03 1989-06-06 Hoechst Aktiengesellschaft Technetium-99m generator, its preparation and its use
DE102006058542A1 (en) * 2006-12-12 2008-06-19 Isotopen Technologien München AG Column system for producing a solution with high specific activity
US20150139870A1 (en) * 2011-03-17 2015-05-21 Perma-Fix Environmental Services, Inc. Preparation of chitosan-based microporous composite material and its applications
US20130336437A1 (en) * 2012-06-15 2013-12-19 Dent International Research, Inc. Apparatus and methods for transmutation of elements
WO2013188793A3 (en) * 2012-06-15 2014-02-13 Dent International Research, Inc. Apparatus and methods for transmutation of elements
CN104488037A (en) * 2012-06-15 2015-04-01 登特国际研究有限公司 Apparatus and methods for transmutation of elements
US9576690B2 (en) * 2012-06-15 2017-02-21 Dent International Research, Inc. Apparatus and methods for transmutation of elements

Also Published As

Publication number Publication date
DE1929067A1 (en) 1970-01-15
GB1280537A (en) 1972-07-05
BE735608A (en) 1970-01-05
CA929685A (en) 1973-07-03
FR2012258A1 (en) 1970-03-13
CS161858B2 (en) 1975-06-10
ES369006A1 (en) 1971-05-01
NL6910212A (en) 1970-01-06
CH501425A (en) 1971-01-15

Similar Documents

Publication Publication Date Title
US3725295A (en) Technetium labeling
Qaim et al. New developments in the production of theranostic pairs of radionuclides
US3664964A (en) Eluent for radioisotopes
Lambrecht Radionuclide generators
US3749556A (en) Radiopharmaceutical generator kit
EP0585986B1 (en) Use of bismuth-213 conjugates for the treatment of micrometastasis
Eisenhut Preparation of 186Re-perrhenate for nuclear medical purposes
US3466361A (en) Technetium-99m labeled chelates
US3740418A (en) Radioactive scanning preparation
CA1252621A (en) Strontium-82/rubidium-82 generator
US20080279772A1 (en) Methods for detecting pathological sites
Welch et al. The potential role of generator-produced radiopharmaceuticals in clinical PET
CA1270845A (en) Aminocarboxylic acid complexes for the treatment of calcific tumors
Vasiliev et al. Various Chromatographic Schemes for Separation of 213Bi from 225Ac☆☆☆
Türler Matched Pair Theranostics: Medicinal Chemistry and Chemical Biology Highlights
UA125583C2 (en) Isotope preparation method
US3787565A (en) Method of producing a diagnostic preparation on the basis of an iron complex labelled with 99m tc
EP0578050A1 (en) A process for the production of yttrium-90 through yttrium-90 generator
Qaim et al. Production of longer-lived positron emitters 73Se, 82mRb and 124I
Ellison et al. Production and isolation of 72As from proton irradiation of enriched 72GeO2 for the development of targeted PET/MRI agents
Jeffries Nonisotopic Labeling
Faintuch et al. Complexation of 188Re-phosphonates: in vitro and in vivo studies
US3663177A (en) Radioactive barium-137
Beyer et al. A 81Rb/81mKr generator made by ion implantation
Chen et al. Treatment of metastatic bone pain with rhenium-188 hydroxyethylidene diphosphonate